Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicityBo Meng, Jenny Kourampa, Adam Abdullahi et al.|Nature|2022Cited by 1.2k
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2Dami A. Collier, Josh Hodgson, Isabella A.T.M. Ferreira et al.|Nature|2021Cited by 816
Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responsesEdward Needham, Marta Correia, Cláudia Fonseca et al.|Brain|2022Cited by 92
SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicityBo Meng, Federica Mescia, Rawlings Datir et al.|Cell Reports|2022Cited by 55
Age-associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockadeJuan Carlos Yam‐Puc, James Thaventhiran, Zhaleh Hosseini et al.|Nature Communications|2023Cited by 45